1 December 2020 | Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study | Gudmundsdottir, V; Pedersen, HK; Mazzoni, G; et al. |
15 March 2020 | Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis | Leete, P; Oram, RA; McDonald, TJ; et al. |
21 July 2020 | Predicting post one-year durability of glucose-lowering monotherapies in patients with newly-diagnosed type 2 diabetes mellitus – A MASTERMIND precision medicine approach (UKPDS 87) | Agbaje, OF; Coleman, RL; Hattersley, AT; et al. |
12 October 2020 | Novel loci for childhood body mass index and shared heritability with adult cardiometabolic traits | Vogelezang, S; Bradfield, JP; Ahluwalia, TS; et al. |
15 December 2020 | Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study | Bizzotto, R; Jennison, C; Jones, AG; et al. |
24 May 2020 | Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation | McGovern, AP; Hogg, M; Shields, BM; et al. |
8 October 2020 | Type 1 Diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta-cells | Johnson, MB; Patel, KA; De Franco, E; et al. |
20 November 2020 | Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors' Expert Forum | Riddle, MC; Philipson, LH; Rich, SS; et al. |
7 December 2020 | Common maternal and fetal genetic variants show expected polygenic effects on risk of small- or large-for-gestational-age (SGA or LGA), except in the smallest 3% of babies | Beaumont, RN; Kotecha, SJ; Wood, AR; et al. |
13 June 2018 | Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. | Misra, S; Vedovato, N; Cliff, E; et al. |